- Report
- June 2025
- 279 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 282 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 372 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 573 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 277 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 275 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 372 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 384 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 285 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 390 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 481 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 266 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 274 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 470 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 468 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 235 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 183 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 171 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 578 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 490 Pages
Global
From €5167EUR$5,850USD£4,413GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more